🇺🇸 FDA
Patent

US 11926824

miRNA biogenesis in exosomes for diagnosis and therapy

granted A61KA61K2039/505A61P

Quick answer

US patent 11926824 (miRNA biogenesis in exosomes for diagnosis and therapy) held by The Board of Regents of the University of Texas System expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61P, A61P25/00, A61P35/00